Biotech • Brain-selective therapies
Montara Therapeutics is a biotech company developing brain-selective therapies for central nervous system diseases using their BrainOnly™ platform.
Biotech • Targeted protein degradation
TRIMTECH Therapeutics is a biotech company developing targeted protein degradation therapeutics for neurodegenerative diseases using TRIMTAC degrader molecules.
Biotech • Small molecule drugs
LoQus23 Therapeutics develops small molecule drugs to halt DNA instability and slow neurodegeneration in triplet repeat diseases like Huntington's disease.
Medical imaging • Coronary stenting
SpectraWAVE, Inc. develops advanced medical imaging systems to improve coronary stenting procedures and enhance clinical decision-making in the treatment of coronary artery disease.
Medical device • Chronic bronchitis
CSA Medical Inc. develops and commercializes the RejuvenAir System, a medical device designed to treat chronic bronchitis.
Biotech • Neurodegenerative Diseases
Harness Therapeutics is a biotech firm specializing in creating oligonucleotide-based drugs to treat neurodegenerative diseases by upregulating protein expression, with a current focus on advancing a treatment for Huntington's Disease towards clinical trials.
Biopharmaceutical • Immunometabolism
Sitryx Therapeutics is a biopharmaceutical company that develops disease-modifying therapeutics for chronic autoimmune and inflammatory diseases by targeting and regulating cell metabolism.
Computational Drug Discovery • Immunology
Nimbus Therapeutics is a clinical-stage company that uses computational chemistry and structure-based drug design to develop novel therapies for immunology, cancer, and metabolic diseases.